{"id":3252,"date":"2025-08-06T16:31:59","date_gmt":"2025-08-06T07:31:59","guid":{"rendered":"https:\/\/atlas.ncc.go.jp\/?page_id=3252"},"modified":"2025-08-06T16:31:59","modified_gmt":"2025-08-06T07:31:59","slug":"ATRAIN_02","status":"publish","type":"page","link":"https:\/\/atlas.ncc.go.jp\/en\/ATRAIN\/ATRAIN_02\/","title":{"rendered":"For participating companies\/list of participating companies"},"content":{"rendered":"<h2>Social significance of A-TRAIN<\/h2>\r\n<ul class=\"list1\">\r\n\t<li>We are carrying out prospective research together with core hospitals in cancer medicine in more than 10 Asian countries, with the aim of promoting cancer genomic medicine.<\/li>\r\n\t<li>We are building a database of clinical information and genetic information of cancer patients in Asia, and are working with pharmaceutical companies regarding the ongoing development of treatments for cancer patients in Asia.<\/li>\r\n\t<li>We are continuing with research while keeping in contact with the regulatory authorities in each country. We are facilitating clinical research in harmony with the regulatory authorities in each country, including when seeking insurance reimbursement for developed devices.<\/li>\r\n<\/ul>\r\n<ol class=\"list1\"><\/ol>\r\n<h2>List of participating facilities<\/h2>\r\n<h3>Japan<\/h3>\r\n<ul class=\"list1 list1_block\">\r\n\t<li>National Cancer Center Hospital, Japan<\/li>\r\n<\/ul>\r\n<h3>Philippines<\/h3>\r\n<ul class=\"list1 list1_block\">\r\n\t<li>St. Luke\u2019s Medical Center, Philippines<\/li>\r\n<\/ul>\r\n<h3>Malaysia<\/h3>\r\n<ul class=\"list1 list1_block\">\r\n\t<li>Hospital Umum Sarawak, Malaysia<\/li>\r\n\t<li>University Malaya Medicine Center, Malaysia<\/li>\r\n\t<li>Hospital Kuala Lumpur, Malaysia<\/li>\r\n\t<li>National Cancer Institute, Malaysia<\/li>\r\n<\/ul>\r\n<h3>Singapore<\/h3>\r\n<ul class=\"list1 list1_block\">\r\n\t<li><span>National University Hospital<\/span><span>\u00a0<\/span><span>,<\/span><span>Singapore<\/span><\/li>\r\n\t<li><span>National Cancer Centre Singapore,\u00a0<\/span><span>Singapore<\/span><\/li>\r\n<\/ul>\r\n<h3>Taiwan<\/h3>\r\n<ul class=\"list1 list1_block\">\r\n\t<li>National Taiwan University Hospital, Taiwan<\/li>\r\n<\/ul>\r\n<h3>Vietnam<\/h3>\r\n<ul class=\"list1 list1_block\">\r\n\t<li>National Cancer Hospital of Vietnam, Vietnam<\/li>\r\n\t<li>Ho Chi Minh City Oncology Hospital Vietnam<\/li>\r\n<\/ul>\r\n<h3>Korea<\/h3>\r\n<ul class=\"list1\">\r\n\t<li>Severance Hospital, Yonsei University Health System<\/li>\r\n<\/ul>\r\n<h2>List of participating companies<\/h2>\r\n<ul class=\"list1 list1_block\">\r\n\t<li class=\"notranslate\" lang=\"en\">Guardant Health Asia, Middle East &amp; Africa (AMEA)<\/li>\r\n\t<li class=\"notranslate\" lang=\"en\">Thermo Fisher Scientific K.K.<\/li>\r\n\t<li class=\"notranslate\" lang=\"en\">Illumina, Inc<\/li>\r\n\t<li class=\"notranslate\" lang=\"en\">Chugai Pharmaceutical Co., Ltd.<\/li>\r\n\t<li class=\"notranslate\" lang=\"en\">Roche Diagnostics K.K.<\/li>\r\n\t<li class=\"notranslate\" lang=\"en\">intellim Corporation<\/li>\r\n\t<li class=\"notranslate\" lang=\"en\">SRL, Inc.<\/li>\r\n\t<li class=\"notranslate\" lang=\"en\">Eurofins<\/li>\r\n<\/ul>","protected":false},"excerpt":{"rendered":"Social significance of A-TRAIN We are carrying out prospective research together with core hospitals in cancer medicine in more than 10 Asian countries, with the aim of promoting cancer genomic medicine. We are building a database of clinical information and genetic information of cancer patients in Asia, and are working with pharmaceutical companies regarding the [&hellip;]","protected":false},"author":23,"featured_media":0,"parent":3216,"menu_order":610,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_locale":"en_US","_original_post":"https:\/\/atlas.ncc.go.jp\/atlasprj_cms\/?page_id=410","footnotes":""},"class_list":["post-3252","page","type-page","status-publish","hentry","en-US"],"acf":[],"_links":{"self":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/pages\/3252","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/comments?post=3252"}],"version-history":[{"count":3,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/pages\/3252\/revisions"}],"predecessor-version":[{"id":3379,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/pages\/3252\/revisions\/3379"}],"up":[{"embeddable":true,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/pages\/3216"}],"wp:attachment":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/media?parent=3252"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}